February 21, 2017 / 2:00 PM / 6 months ago

BRIEF-Cidara Therapeutics reports unfavorable results of Phase 2 radiant trial of CD101 topical in VVC

Feb 21 (Reuters) - Cidara Therapeutics Inc

* Cidara Therapeutics reports unfavorable results of Phase 2 radiant trial of CD101 topical in VVC

* Cidara Therapeutics Inc - further development of CD101 topical for VVC to be discontinued

* Cidara Therapeutics Inc says further development of CD101 topical for VVC to be discontinued

* Cidara Therapeutics Inc - CD101 IV development program in Candidemia and invasive Candidiasis continuing and remains on track

* Cidara Therapeutics Inc says CD101 gel and ointment were well-tolerated Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below